Rybelsus vs Metformin
A side-by-side look at two diabetes medications advertised on TV. Informational only — not medical advice.
| US Rybelsus | US Metformin | |
|---|---|---|
| Generic name | semaglutide | metformin |
| Drug class | GLP-1 Receptor Agonist | Biguanide |
| Treats | Type 2 diabetes | Type 2 diabetes |
| Category | Diabetes | Diabetes |
| Manufacturer | Novo Nordisk | Various (generic) |
| Year approved | 2019 | 1995 |
| FDA warning | Black box warning | Black box warning |
| Est. TV ad spend | $180M | $2M |
| Common side effects | Nausea, Abdominal pain, Diarrhea, Decreased appetite | Nausea, Diarrhea, Abdominal discomfort, Vitamin B12 deficiency |
Metformin
Frequently asked questions
Is Rybelsus or Metformin better?
Neither is universally "better." Rybelsus (semaglutide) and Metformin (metformin) are both used for diabetes, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Rybelsus and Metformin?
Rybelsus is a GLP-1 Receptor Agonist made by Novo Nordisk, while Metformin is a Biguanide made by Various (generic). See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Rybelsus has the larger estimated TV advertising budget of the two.